Cargando…
Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is an asbestos‐related aggressive malignant neoplasm. Due to the difficulty of achieving curative surgical resection in most patients with MPM, a combination chemotherapy of cisplatin and pemetrexed has been the only approved regimen proven to improve the prognos...
Autores principales: | Horio, Daisuke, Minami, Toshiyuki, Kitai, Hidemi, Ishigaki, Hirotoshi, Higashiguchi, Yoko, Kondo, Nobuyuki, Hirota, Seiichi, Kitajima, Kazuhiro, Nakajima, Yasuhiro, Koda, Yuichi, Fujimoto, Eriko, Negi, Yoshiki, Niki, Maiko, Kanemura, Shingo, Shibata, Eisuke, Mikami, Koji, Takahashi, Ryo, Yokoi, Takashi, Kuribayashi, Kozo, Kijima, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419052/ https://www.ncbi.nlm.nih.gov/pubmed/32530527 http://dx.doi.org/10.1111/cas.14523 |
Ejemplares similares
-
Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report
por: Fujimoto, Eriko, et al.
Publicado: (2018) -
Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021) -
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
por: Tabata, Chiharu, et al.
Publicado: (2013) -
Deep learning with deep convolutional neural network using FDG-PET/CT for malignant pleural mesothelioma diagnosis
por: Kitajima, Kazuhiro, et al.
Publicado: (2021) -
Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors–Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment
por: Yoshikawa, Yoshie, et al.
Publicado: (2020)